assembly_id	genome_id	genome_def	crispr_array_locus_merge	crispr_array_location_merge	crispr_locus_id	crispr_pred_method	array_in_prot	prot_within_array_20000	prot_in_genome	crispr_type_by_cas_prot	consensus_repeat	repeat_length	self-targeting_spacer_number	self-targeting_target_number	spacer_location	protospacer_location	repeat_type	spacer_locus_num	spacer_num	correct_crispr_type	genome_cas_prots	unknown_protein_around_crispr	L10	L10_domain	L9	L9_domain	L8	L8_domain	L7	L7_domain	L6	L6_domain	L5	L5_domain	L4	L4_domain	L3	L3_domain	L2	L2_domain	L1	L1_domain	R1	R1_domain	R2	R2_domain	R3	R3_domain	R4	R4_domain	R5	R5_domain	R6	R6_domain	R7	R7_domain	R8	R8_domain	R9	R9_domain	R10	R10_domain
GCF_013098855.1_ASM1309885v1	NZ_CP040010	TM7 phylum sp. oral taxon 488 strain CM003 chromosome, complete genome	1	170896-170971	1	CRISPRCasFinder	no		csn2,cas2,cas1,cas9,DEDDh	Orphan	ACGGAACCGTCAATGGTGATGTCTA	25	0	0	NA	NA	NA	1	1	Orphan	csn2,cas2,cas1,cas9,DEDDh	NA|92aa|up_3|NZ_CP040010.1_165708_165984_+,NA|82aa|down_1|NZ_CP040010.1_172236_172482_+,NA|262aa|down_7|NZ_CP040010.1_176990_177776_+	NA|152aa|up_9|NZ_CP040010.1_160906_161362_+	pfam09424, YqeY, Yqey-like protein	NA|184aa|up_8|NZ_CP040010.1_161381_161933_+	PRK00279, adk, adenylate kinase; Reviewed	NA|255aa|up_7|NZ_CP040010.1_161920_162685_+	cd01086, MetAP1, Methionine Aminopeptidase 1	NA|412aa|up_6|NZ_CP040010.1_162720_163956_+	COG0849, ftsA, Cell division ATPase FtsA [Cell division and chromosome partitioning]	NA|398aa|up_5|NZ_CP040010.1_164033_165227_+	PRK09330, PRK09330, cell division protein FtsZ; Validated	NA|150aa|up_4|NZ_CP040010.1_165252_165702_+	PRK00464, nrdR, transcriptional repressor NrdR	NA|92aa|up_3|NZ_CP040010.1_165708_165984_+	NA	NA|203aa|up_2|NZ_CP040010.1_165967_166576_+	cd12922, VKOR_5, Vitamin K epoxide reductase family in bacteria	NA|280aa|up_1|NZ_CP040010.1_166849_167689_+	PRK00865, PRK00865, glutamate racemase; Provisional	NA|959aa|up_0|NZ_CP040010.1_167772_170649_+	PRK06039, ileS, isoleucyl-tRNA synthetase; Reviewed	NA|57aa|down_0|NZ_CP040010.1_171922_172093_+	pfam04024, PspC, PspC domain	NA|82aa|down_1|NZ_CP040010.1_172236_172482_+	NA	NA|102aa|down_2|NZ_CP040010.1_172550_172856_+	pfam00829, Ribosomal_L21p, Ribosomal prokaryotic L21 protein	NA|255aa|down_3|NZ_CP040010.1_172945_173710_+	pfam13614, AAA_31, AAA domain	NA|296aa|down_4|NZ_CP040010.1_173699_174587_+	TIGR04285, parB-like_partition_protein, nucleoid occlusion protein	NA|203aa|down_5|NZ_CP040010.1_174596_175205_-	TIGR02227, Inactive_signal_peptidase_IA	NA|556aa|down_6|NZ_CP040010.1_175301_176969_+	COG1316, LytR, Transcriptional regulator [Transcription]	NA|262aa|down_7|NZ_CP040010.1_176990_177776_+	NA	NA|384aa|down_8|NZ_CP040010.1_177804_178956_+	TIGR02037, Probable_periplasmic_serine_protease_do/HhoA-like, periplasmic serine protease, Do/DeqQ family	NA|274aa|down_9|NZ_CP040010.1_178948_179770_-	TIGR03534, RF_mod_PrmC, protein-(glutamine-N5) methyltransferase, release factor-specific
GCF_013098855.1_ASM1309885v1	NZ_CP040010	TM7 phylum sp. oral taxon 488 strain CM003 chromosome, complete genome	2	263458-264285	1,2,1	PILER-CR,CRISPRCasFinder,CRT	no	csn2,cas2,cas1,cas9	csn2,cas2,cas1,cas9,DEDDh	Type II-C,Type II-A,Type II-B	GTTTCAGTACCATTCAATATAACACTACTGTAAAAC,GTTTCAGTACCATTCAATATAACACTACTGTAAAAC,GTTTCAGTACCATTCAATATAACACTACTGTAAAAC	36,36,36	0	0	NA	NA	NA:NA:NA	12,12,12	12	TypeII-C,TypeII-A,TypeII-B	csn2,cas2,cas1,cas9,DEDDh	NA|117aa|up_7|NZ_CP040010.1_246620_246971_+,NA|317aa|up_2|NZ_CP040010.1_252244_253195_+,NA|95aa|down_8|NZ_CP040010.1_277429_277714_-,NA|142aa|down_9|NZ_CP040010.1_278129_278555_-	NA|337aa|up_9|NZ_CP040010.1_243787_244798_+	pfam01933, UPF0052, Uncharacterized protein family UPF0052	NA|297aa|up_8|NZ_CP040010.1_245520_246411_+	PRK00050, PRK00050, 16S rRNA (cytosine(1402)-N(4))-methyltransferase RsmH	NA|117aa|up_7|NZ_CP040010.1_246620_246971_+	NA	NA|584aa|up_6|NZ_CP040010.1_246983_248735_+	COG0768, FtsI, Cell division protein FtsI/penicillin-binding protein 2 [Cell envelope biogenesis, outer membrane]	NA|349aa|up_5|NZ_CP040010.1_248754_249801_+	cd06852, GT_MraY, Phospho-N-acetylmuramoyl-pentapeptide-transferase (mraY) is an enzyme responsible for the formation of the first lipid intermediate in the synthesis of bacterial cell wall peptidoglycan	NA|440aa|up_4|NZ_CP040010.1_249803_251123_+	COG0772, FtsW, Bacterial cell division membrane protein [Cell division and chromosome partitioning]	NA|386aa|up_3|NZ_CP040010.1_251049_252207_+	PRK00726, murG, undecaprenyldiphospho-muramoylpentapeptide beta-N- acetylglucosaminyltransferase; Provisional	NA|317aa|up_2|NZ_CP040010.1_252244_253195_+	NA	NA|2476aa|up_1|NZ_CP040010.1_254590_262018_+	pfam03382, DUF285, Mycoplasma protein of unknown function, DUF285	NA|194aa|up_0|NZ_CP040010.1_262078_262660_-	cd02883, Nudix_Hydrolase, Nudix hydrolase is a superfamily of enzymes found in all three kingdoms of life, and it catalyzes the hydrolysis of NUcleoside DIphosphates linked to other moieties, X	csn2|230aa|down_0|NZ_CP040010.1_264339_265029_-	cd09644, Csn2, CRISPR/Cas system-associated protein Csn2	cas2|107aa|down_1|NZ_CP040010.1_265025_265346_-	COG3512, COG3512, CRISPR-associated protein, Cas2 homolog [Defense mechanisms]	cas1|293aa|down_2|NZ_CP040010.1_265348_266227_-	cd09720, Cas1_II, CRISPR/Cas system-associated protein Cas1	cas9|881aa|down_3|NZ_CP040010.1_266230_268873_-	TIGR01865, conserved_hypothetical_protein, CRISPR subtype II/NMENI RNA-guided endonuclease Cas9/Csn1	cas9|423aa|down_4|NZ_CP040010.1_268983_270252_-	pfam16592, Cas9_REC, REC lobe of CRISPR-associated endonuclease Cas9	NA|941aa|down_5|NZ_CP040010.1_270531_273354_-	COG0433, COG0433,  HerA helicase [Replication, recombination, and repair]	NA|363aa|down_6|NZ_CP040010.1_273478_274567_-	COG0568, RpoD, DNA-directed RNA polymerase, sigma subunit (sigma70/sigma32) [Transcription]	NA|781aa|down_7|NZ_CP040010.1_274975_277318_-	PRK07561, PRK07561, DNA topoisomerase I subunit omega; Validated	NA|95aa|down_8|NZ_CP040010.1_277429_277714_-	NA	NA|142aa|down_9|NZ_CP040010.1_278129_278555_-	NA
